Fungoides Mycosis Sezary Syndrome
1 clinical trials · Condition
◉ Watch Fungoides Mycosis Sezary Syndrome
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas (NCT05956041) | University of Michigan Rogel Cancer Center | 2023-12-06 |
Track Fungoides Mycosis Sezary Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.